ASND Ascendis Pharma A/S Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
02:54
Aug 18
FirstSquawk
JPMorgan raises its target price on Ascendis Pharma to $300 from $295. News
JPMorgan raises its target price on Ascendis Pharma to $300 from $295, indicating a bullish outlook on the stock.
ASND Ascendis Pharma A/S Long 1ST — —
09:20
Jan 24
u/DrinkConscious9173
r/biotech_stocks
Long ASND ahead of PDUFA with 93% ML score.
The author's ML model holds ASND long ahead of a PDUFA catalyst in 32 days, assigning a 93% confidence score for a positive catalyst outcome. A favorable FDA decision could push the stock toward the $261.33 target; the trade is invalidated below the $209.06 stop loss.
ASND Ascendis Pharma A/S Long 1ST — —
08:43
Jan 24
seedy19tron
ASND holding running after earlier adds
The author holds Ascendis Pharma, which they added to earlier this month and which has been running. There is no ASND-specific rationale beyond the author's general view that every portfolio holding is undervalued.
ASND Ascendis Pharma A/S Long Position: Holding —
Log in to see ideas

About ASND Investor Commentary

Across the available history and selected sources, Buzzberg tracks ASND (Ascendis Pharma A/S) across 3 sources: 4 bullish vs 0 bearish calls from 3 authors. Historical directional balance: 44% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 9 total trade ideas tracked. Latest voices: FirstSquawk, u/DrinkConscious9173, seedy19tron.